Kim, Hyunju
Lichtenstein, Alice H.
Ganz, Peter
Miller, Edgar R. III
Coresh, Josef
Appel, Lawrence J.
Rebholz, Casey M.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005, R01 HL153178)
National Institute of Diabetes and Digestive and Kidney Diseases (R03 DK128386)
Article History
Received: 5 November 2022
Accepted: 19 June 2023
First Online: 3 July 2023
Declarations
:
: For the OmniHeart trial, procedures were followed in accordance with the ethical standards of the institutional review boards (Johns Hopkins Medical Institutions and Brigham and Women’s Hospital) at the two sites and abide by the Declaration of Helsinki principles, and participants provided written informed consent. For the ARIC Study, procedures were followed in accordance with the ethical standards of the Institutional Review Boards at all study sites (Johns Hopkins Bloomberg School of Public Health, University of North Carolina, Chapel Hill, University of Mississippi Medical Center, Wake Forest Baptist Medical Center, University of Minnesota, Minneapolis), and participants provided informed consent.
: Not applicable.
: The authors declare no competing interests.